Get all your news in one place.

100's of premium titles.
One app.

Get all your news in one place.

100's of premium titles. One news app.

THE TRUTH ABOUT: 4 - The Untold Story

The pharmaceutical industry is anticipated to grow due to rising chronic diseases and an aging population. Given the industry's strong long-term prospects, quality stocks Novo Nordisk (NVO), Novartis (NVS), and Bristol-Myers Squibb (BMY) could be worth adding to your watchlist. Continue reading….

StockNews.com

Short Straddle Screener Results For April 13th

The screener shows some interesting short straddle trades on popular stocks such as BMY, AAPL, VZ, CRM, GOOG, INTC, PANW, XOM and TSLA.

Barchart

Stay Forever Young With These 3 Pharmaceutical Stocks

Despite macroeconomic headwinds, the pharmaceutical industry is anticipated to stay buoyed in the foreseeable future, owing to rising healthcare spending. Against this backdrop, we think the strong fundamentals of Novo Nordisk (NVO), Bristol-Myers Squibb (BMY), and Takeda Pharmaceutical (TAK) make them wise portfolio additions. Read on….

StockNews.com

From analysis to the latest developments in health,
read the most diverse news in one place.

3 Large-Cap Pharma Stocks to Protect Your Portfolio Through 2023

The worst banking crisis since 2008 could not stop the Fed from raising the benchmark interest rate. The possibility of further policy tightening and strict lending standards for banks might push the economy into a recession this year. Therefore, investing in large-cap pharma stocks Johnson & Johnson (JNJ), Merck &…

StockNews.com

4 Best Pharma Stocks to Buy for the Long Haul

With the persistent rise in lifestyle diseases, the pharmaceutical industry is well poised for strong growth in the long term. Also, with the Fed likely to keep increasing the interest rates, the economy is likely to enter a recession, making pharma stocks attractive investment options. Therefore, investors could look to…

StockNews.com

3 Value Stocks You Won't Regret Buying in 2023

With the Fed’s measures to counter inflation causing the collateral damage of asset price deflation, it could be wise to load up on Bristol-Myers Squibb (BMY), Gilead Sciences (GILD), and DoubleDown Interactive (DDI), available at attractive valuations to capture future upside potential while limiting downside risks. Continue reading….

StockNews.com

The 5 Best Stocks to Buy and Watch in 2023

Recent rhetoric from the Federal Reserve, the collapse of the Silicon Valley Bank, and strong economic data have now resulted in an extremely volatile market backdrop. Against this, adding fundamentally sound stocks Bristol-Myers Squibb (BMY), General Motors (GM), McKesson Corp. (MCK), Cardinal Health (CAH), and American Vanguard (AVD) to your…

StockNews.com

Read news from The Economist, FT, and more,
with one subscription

1 Stock to Buy This Week and Hold for the Next 20 Years

Although the stock market remains highly volatile, investing for the long term can never be timed perfectly. I believe buying fundamentally strong biopharmaceutical major Bristol-Myers Squibb (BMY) now for the long term could be wise, given the solid prospects of its new drug launches. Read more….

StockNews.com

2 Dividend Stocks That Could Pay You for the Rest of Your Life

As the market remains volatile due to ongoing concerns about elevated inflation, prolonged rate hikes, and an impending recession, fundamentally strong dividend stocks Bristol-Myers Squibb (BMY) Gilead Sciences (GILD) might be ideal buys to ensure a stable income stream. Moreover, these stocks could be great long-term investments. Read more.

StockNews.com

4 Stocks to Buy in Any Market Climate

The stock market is expected to remain volatile in the near term as investors remain anxious about the Fed’s actions. Amid high recession worries, fundamentally strong healthcare stocks, Pfizer (PFE), Bristol-Myers Squibb (BMY), Amgen (AMGN), and Elevance Health (ELV), which have the potential to withstand any market downturns, could be…

StockNews.com

3 Best Stocks to Own for Passive Income in 2023

The Fed is expected to keep hiking rates to achieve its target inflation rate. Amid rising volatility, investor sentiment toward dividend investing has been improving. Here are three quality dividend-paying stocks, Novartis (NVS), Bristol-Myers Squibb (BMY), and Canon (CAJ), which will ensure a steady passive income stream in 2023. Keep…

StockNews.com

2 Pharma Stocks to Buy Right Now and 1 You Might Want to Consider Selling

The pharmaceutical industry is evolving with personalized medicines and the rapid adoption of RPM technology, which should boost growth. Moreover, with a recession lurking, fundamentally strong pharma stocks AstraZeneca (AZN) and Bristol-Myers Squibb (BMY) might be ideal buys. However, SNDL (SNDL) might be best avoided. Keep reading to know why.

StockNews.com

3 Stocks to Safeguard Your Portfolio in 2023

The stock market’s outlook seems choppy as investors weigh data on the state of the economy, labor market, and future rate increases by the Federal Reserve. With more volatility expected for the near term, one should consider safeguarding their portfolios with fundamentally sound stocks Coca-Cola (KO), Bristol-Myers Squibb (BMY), and…

StockNews.com

Is Bristol-Myers a Good Dividend Stock to Pick up Right Now?

Leading pharma company Bristol-Myers Squibb’s (BMY) fiscal year 2022 revenue and EPS were in line with analysts’ estimates. While BMY continues to advance its innovative portfolio and pipeline, is it a good dividend stock to pick up right now? Read more to find out.

StockNews.com

Get all your
news in one place.

100's of premium titles.
One news app.

StockNews.com

4 Pharma Stocks to Buy Now for the Long Haul

The pharma industry has experienced tremendous growth in recent years. The industry should continue to grow, driven by the growing market for personalized medicine and e-pharmacies. Hence, pharma stocks Pfizer (PFE), AstraZeneca (AZN), Bristol-Myers Squibb (BMY), and Zoetis (ZTS) might be worth buying for the long term. Also, these companies…

StockNews.com

4 Great Stocks to Buy Now for Under $100

Monthly inflation inched up in January. Moreover, the Fed could be forced to raise the benchmark rate higher than forecasted. Amid this backdrop, it could be wise for investors to buy fundamentally strong stocks Coca-Cola (KO), Bristol-Myers Squibb (BMY), Cardinal Health (CAH), and Bluegreen Vacations Holding (BVH), currently trading under…

StockNews.com

2 Stocks to Help You Sail Through This Volatile Market

Although favorable macro data rekindled investor optimism, the Fed’s intention of raising rates to tame stubbornly high inflation could possibly tip the economy into recession. With anxiety escalating, it would be wise to add quality stocks Johnson & Johnson (JNJ) and Bristol-Myers Squibb (BMY) to your portfolio to sail through…

StockNews.com

Start 2023 out Right. Add These 2 Stocks to Your Portfolio Today

Cooling inflationary pressures, a slowdown in the Fed’s interest rate hikes, and easing recession fears are contributing to improved investor sentiment lately. Amid growing investor optimism, fundamentally sound stocks Bristol-Myers Squibb (BMY) and General Motors (GM) could be wise additions to your portfolio to start 2023 right. Continue reading….

Get all your
news in one place.

100's of premium titles.
One news app.

StockNews.com

3 Pharma Stocks to Buy in 2023 and Hold for Decades

The pharmaceutical industry is well-positioned for significant growth in the near future, given the growing demand for medicines and increasing R&D activities. Given the industry's inelastic demand, fundamentally strong pharma stocks AstraZeneca (AZN), Bristol-Myers Squibb (BMY), and GSK plc (GSK) might be solid long-term investments. Continue reading….

StockNews.com

Owning These 3 Stocks Could Make You Rich in 10 Years

Consistently falling prices and stronger-than-expected fourth-quarter GDP are renewing hopes about the economy’s overall health. Therefore, it could be wise to add quality stocks with solid fundamentals, Walmart (WMT), Bristol-Myers Squibb (BMY), and CVS Health (CVS), to your portfolio to garner substantial returns in 10 years. Read more….

StockNews.com

3 Stocks to Buy Right Now if You Want to Retire Early

The Fed’s indication to keep raising interest rates through this year and looming recession fears will likely keep the stock market under pressure for the near term. Therefore, investors looking for stability amid an uncertain macroeconomic environment could consider buying fundamentally strong dividend-paying healthcare stocks Johnson & Johnson (JNJ), Pfizer…

StockNews.com

3 "Strong Buy" Stocks You Don't Want to Miss out on in 2023

The incessant rate hikes have led to significant market volatility and raised recessionary fears. However, with inflation finally cooling and wage growth slowing down, we think fundamentally strong stocks Bristol-Myers Squibb (BMY), Cardinal Health (CAH), and KT Corp (KT), which are rated A (Strong Buy) in our proprietary rating system,…

StockNews.com

3 Stocks to Buy to Build a Millionaire Portfolio

Inflation eased for the second consecutive month in November, and the Fed slowed down the pace of rate hikes after four straight 75-basis-point hikes. However, recession fears loom as the central bank plans to raise rates through next year. Regardless of the economic uncertainties, it could be wise to invest…

StockNews.com

The Best Medical Stock to Buy Right Now for Under $100

Despite macroeconomic challenges, leading pharma company Bristol-Myers Squibb (BMY) has the robustness and resilience to deliver value for shareholders. Read on….

StockNews.com

2 Medical Stocks to Buy Now With Hefty Yields

Despite rampant market volatility, Goldman Sachs expects the U.S. economy to avoid a recession. However, as uncertainties remain, medical stocks Pfizer (PFE) and Bristol-Myers Squibb (BMY), which pay reliable dividends, could be ideal buys to ensure a steady income stream. Keep reading….

1 … 3 4 5 6

People

Dipanjan BanchurSince

722 stories

Santanu RoyHaving

215 stories

Sristi Suman Jayaswal

90 stories

Mike Wilson

68 stories

From analysis to the latest developments in health,
read the most diverse news in one place.

Organisations

Read news from The Economist, FT, and more,
with one subscription

Topics

Places

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.